241 related articles for article (PubMed ID: 37565977)
1. Interleukin-6 in Patients With Heart Failure and Preserved Ejection Fraction.
Alogna A; Koepp KE; Sabbah M; Espindola Netto JM; Jensen MD; Kirkland JL; Lam CSP; Obokata M; Petrie MC; Ridker PM; Sorimachi H; Tchkonia T; Voors A; Redfield MM; Borlaug BA
JACC Heart Fail; 2023 Nov; 11(11):1549-1561. PubMed ID: 37565977
[TBL] [Abstract][Full Text] [Related]
2. Quality of life in heart failure with preserved ejection fraction: importance of obesity, functional capacity, and physical inactivity.
Reddy YNV; Rikhi A; Obokata M; Shah SJ; Lewis GD; AbouEzzedine OF; Dunlay S; McNulty S; Chakraborty H; Stevenson LW; Redfield MM; Borlaug BA
Eur J Heart Fail; 2020 Jun; 22(6):1009-1018. PubMed ID: 32150314
[TBL] [Abstract][Full Text] [Related]
3. Distinct Impact of Noncardiac Comorbidities on Exercise Capacity and Functional Status in Chronic Heart Failure.
Martens P; Augusto SN; Finet JE; Tang WHW
JACC Heart Fail; 2023 Oct; 11(10):1365-1376. PubMed ID: 37389503
[TBL] [Abstract][Full Text] [Related]
4. Characterization of the Obese Phenotype of Heart Failure With Preserved Ejection Fraction: A RELAX Trial Ancillary Study.
Reddy YNV; Lewis GD; Shah SJ; Obokata M; Abou-Ezzedine OF; Fudim M; Sun JL; Chakraborty H; McNulty S; LeWinter MM; Mann DL; Stevenson LW; Redfield MM; Borlaug BA
Mayo Clin Proc; 2019 Jul; 94(7):1199-1209. PubMed ID: 31272568
[TBL] [Abstract][Full Text] [Related]
5. Effect of Inorganic Nitrite vs Placebo on Exercise Capacity Among Patients With Heart Failure With Preserved Ejection Fraction: The INDIE-HFpEF Randomized Clinical Trial.
Borlaug BA; Anstrom KJ; Lewis GD; Shah SJ; Levine JA; Koepp GA; Givertz MM; Felker GM; LeWinter MM; Mann DL; Margulies KB; Smith AL; Tang WHW; Whellan DJ; Chen HH; Davila-Roman VG; McNulty S; Desvigne-Nickens P; Hernandez AF; Braunwald E; Redfield MM;
JAMA; 2018 Nov; 320(17):1764-1773. PubMed ID: 30398602
[TBL] [Abstract][Full Text] [Related]
6. Cardiovascular phenotype in HFpEF patients with or without diabetes: a RELAX trial ancillary study.
Lindman BR; Dávila-Román VG; Mann DL; McNulty S; Semigran MJ; Lewis GD; de las Fuentes L; Joseph SM; Vader J; Hernandez AF; Redfield MM
J Am Coll Cardiol; 2014 Aug; 64(6):541-9. PubMed ID: 25104521
[TBL] [Abstract][Full Text] [Related]
7. Impact of atrial fibrillation on exercise capacity in heart failure with preserved ejection fraction: a RELAX trial ancillary study.
Zakeri R; Borlaug BA; McNulty SE; Mohammed SF; Lewis GD; Semigran MJ; Deswal A; LeWinter M; Hernandez AF; Braunwald E; Redfield MM
Circ Heart Fail; 2014 Jan; 7(1):123-30. PubMed ID: 24162898
[TBL] [Abstract][Full Text] [Related]
8. Resting ventricular-vascular function and exercise capacity in heart failure with preserved ejection fraction: a RELAX trial ancillary study.
Mohammed SF; Borlaug BA; McNulty S; Lewis GD; Lin G; Zakeri R; Semigran MJ; LeWinter M; Hernandez AF; Braunwald E; Redfield MM
Circ Heart Fail; 2014 Jul; 7(4):580-9. PubMed ID: 24833648
[TBL] [Abstract][Full Text] [Related]
9. Galectin-3 in heart failure with preserved ejection fraction. A RELAX trial substudy (Phosphodiesterase-5 Inhibition to Improve Clinical Status and Exercise Capacity in Diastolic Heart Failure).
AbouEzzeddine OF; Haines P; Stevens S; Nativi-Nicolau J; Felker GM; Borlaug BA; Chen HH; Tracy RP; Braunwald E; Redfield MM
JACC Heart Fail; 2015 Mar; 3(3):245-52. PubMed ID: 25742762
[TBL] [Abstract][Full Text] [Related]
10. Regional Adipose Distribution and its Relationship to Exercise Intolerance in Older Obese Patients Who Have Heart Failure With Preserved Ejection Fraction.
Haykowsky MJ; Nicklas BJ; Brubaker PH; Hundley WG; Brinkley TE; Upadhya B; Becton JT; Nelson MD; Chen H; Kitzman DW
JACC Heart Fail; 2018 Aug; 6(8):640-649. PubMed ID: 30007558
[TBL] [Abstract][Full Text] [Related]
11. INDIE-HFpEF (Inorganic Nitrite Delivery to Improve Exercise Capacity in Heart Failure With Preserved Ejection Fraction): Rationale and Design.
Reddy YNV; Lewis GD; Shah SJ; LeWinter M; Semigran M; Davila-Roman VG; Anstrom K; Hernandez A; Braunwald E; Redfield MM; Borlaug BA
Circ Heart Fail; 2017 May; 10(5):. PubMed ID: 28476756
[TBL] [Abstract][Full Text] [Related]
12. Suppression of Tumorigenicity 2 in Heart Failure With Preserved Ejection Fraction.
AbouEzzeddine OF; McKie PM; Dunlay SM; Stevens SR; Felker GM; Borlaug BA; Chen HH; Tracy RP; Braunwald E; Redfield MM
J Am Heart Assoc; 2017 Feb; 6(2):. PubMed ID: 28214792
[TBL] [Abstract][Full Text] [Related]
13. Effect of endurance exercise training on endothelial function and arterial stiffness in older patients with heart failure and preserved ejection fraction: a randomized, controlled, single-blind trial.
Kitzman DW; Brubaker PH; Herrington DM; Morgan TM; Stewart KP; Hundley WG; Abdelhamed A; Haykowsky MJ
J Am Coll Cardiol; 2013 Aug; 62(7):584-92. PubMed ID: 23665370
[TBL] [Abstract][Full Text] [Related]
14. Accelerometer-Measured Daily Activity in Heart Failure With Preserved Ejection Fraction: Clinical Correlates and Association With Standard Heart Failure Severity Indices.
Snipelisky D; Kelly J; Levine JA; Koepp GA; Anstrom KJ; McNulty SE; Zakeri R; Felker GM; Hernandez AF; Braunwald E; Redfield MM
Circ Heart Fail; 2017 Jun; 10(6):e003878. PubMed ID: 28588021
[TBL] [Abstract][Full Text] [Related]
15. Impaired Right Ventricular-Pulmonary Arterial Coupling and Effect of Sildenafil in Heart Failure With Preserved Ejection Fraction: An Ancillary Analysis From the Phosphodiesterase-5 Inhibition to Improve Clinical Status And Exercise Capacity in Diastolic Heart Failure (RELAX) Trial.
Hussain I; Mohammed SF; Forfia PR; Lewis GD; Borlaug BA; Gallup DS; Redfield MM
Circ Heart Fail; 2016 Apr; 9(4):e002729. PubMed ID: 27072860
[TBL] [Abstract][Full Text] [Related]
16. Effect of phosphodiesterase-5 inhibition on exercise capacity and clinical status in heart failure with preserved ejection fraction: a randomized clinical trial.
Redfield MM; Chen HH; Borlaug BA; Semigran MJ; Lee KL; Lewis G; LeWinter MM; Rouleau JL; Bull DA; Mann DL; Deswal A; Stevenson LW; Givertz MM; Ofili EO; O'Connor CM; Felker GM; Goldsmith SR; Bart BA; McNulty SE; Ibarra JC; Lin G; Oh JK; Patel MR; Kim RJ; Tracy RP; Velazquez EJ; Anstrom KJ; Hernandez AF; Mascette AM; Braunwald E;
JAMA; 2013 Mar; 309(12):1268-77. PubMed ID: 23478662
[TBL] [Abstract][Full Text] [Related]
17. Hemodynamic Gain Index and Exercise Capacity in Heart Failure With Preserved Ejection Fraction.
Morales-Oyarvide V; Richards D; Hendren NS; Michelis K; Chaikijurajai T; MacNamara JP; Sarma S; Farr MA; Drazner MH; Tang WHW; Grodin JL
Am J Cardiol; 2023 Mar; 190():17-24. PubMed ID: 36543076
[TBL] [Abstract][Full Text] [Related]
18. The neurohormonal basis of pulmonary hypertension in heart failure with preserved ejection fraction.
Obokata M; Kane GC; Reddy YNV; Melenovsky V; Olson TP; Jarolim P; Borlaug BA
Eur Heart J; 2019 Dec; 40(45):3707-3717. PubMed ID: 31513270
[TBL] [Abstract][Full Text] [Related]
19. Left atrial function and maximal exercise capacity in heart failure with preserved and mid-range ejection fraction.
Maffeis C; Morris DA; Belyavskiy E; Kropf M; Radhakrishnan AK; Zach V; Rozados da Conceicao C; Trippel TD; Pieske-Kraigher E; Rossi A; Pieske B; Edelmann F
ESC Heart Fail; 2021 Feb; 8(1):116-128. PubMed ID: 33295106
[TBL] [Abstract][Full Text] [Related]
20. Inorganic Nitrite to Amplify the Benefits and Tolerability of Exercise Training in Heart Failure With Preserved Ejection Fraction: The INABLE-Training Trial.
Borlaug BA; Koepp KE; Reddy YNV; Obokata M; Sorimachi H; Freund M; Haberman D; Sweere K; Weber KL; Overholt EA; Safe BA; Omote K; Omar M; Popovic D; Acker NG; Gladwin MT; Olson TP; Carter RE
Mayo Clin Proc; 2024 Feb; 99(2):206-217. PubMed ID: 38127015
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
